* Teladoc Health Inc TDOC.N reported a quarterly adjusted
loss
of 19 cents per share for the quarter ended September 30,
higher than the same quarter last year, when the company
reported EPS of -35 cents. The mean expectation of twenty
six analysts for the quarter was for a loss of 28 cents per
share. Wall Street expected results to range from -37 cents
to -13 cents per share.
* Revenue fell 3% to $640.51 million from a year ago;
analysts
expected $631.16 million.
* Teladoc Health Inc's reported EPS for the quarter was a
loss
of 19 cents.
* The company reported a quarterly loss of $33.28 million.
* Teladoc Health Inc shares had fallen by 2.8% this
quarter and
lost 58.6% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 11.1%
in the last three months.
* In the last 30 days, two analysts negatively revised
earnings
estimates
RECOMMENDATIONS
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 21
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the healthcare
facilities & services peer group is also "hold"
Wall Street's median 12-month price target for Teladoc Health
Inc is 10.00
This summary was machine generated from LSEG data October 31 at
02:42 a.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 -0.28 -0.19 Beat
Jun. 30 2024 -0.35 -0.28 Beat
Mar. 31 2024 -0.46 -0.49 Missed
Dec. 31 2023 -0.21 -0.17 Beat